Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Molly P Hogan"'
Publikováno v:
Clinical Imaging. 96:34-37
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0613af38e15aff3ee45a1942bbb5381f
https://doi.org/10.1016/j.clinimag.2022.12.012
https://doi.org/10.1016/j.clinimag.2022.12.012
Autor:
Molly P. Hogan, Joao V. Horvat, Dara S. Ross, Varadan Sevilimedu, Maxine S. Jochelson, Laurie J. Kirstein, Shari B. Goldfarb, Christopher E. Comstock, Janice S. Sung
Publikováno v:
Breast Cancer Research and Treatment. 198:349-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cf5db8207b63d4f44518991e4da0e60e
https://doi.org/10.1007/s10549-023-06865-8
https://doi.org/10.1007/s10549-023-06865-8
Publikováno v:
Clinical Imaging. 93:31-33
Contrast-enhanced mammography (CEM) may provide an alternative to magnetic resonance imaging as a diagnostic exam in women with known or suspected breast cancer or as a screening exam in women at increased risk of breast cancer. Women with breast aug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d75f5730371c3da1c0824e5a1ff962c5
https://doi.org/10.1016/j.clinimag.2022.10.012
https://doi.org/10.1016/j.clinimag.2022.10.012
Autor:
Astrid Botty Van den Bruele, Tiana Le, Monica Fornier, Varadan Sevilimedu, Monica Morrow, Emanuela Ferraro, Molly P Hogan, Virgilio Sacchini, Sidra Javed-Tayyab
Publikováno v:
Breast Cancer Research and Treatment. 189:307-315
HER2 +- amplified breast cancer patients derive benefit from treatment with anti-HER2-targeted therapy. Though adjuvant treatment is based on final pathology, decisions regarding neoadjuvant chemotherapy are made in the preoperative setting with imag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d208dcd4e6b5fcdfacf159b61223d63
https://doi.org/10.1007/s10549-021-06331-3
https://doi.org/10.1007/s10549-021-06331-3
Autor:
Janice S. Sung, Molly P Hogan, Maxine S. Jochelson, Elizabeth A. Morris, Tali Amir, Varadan Sevilimedu
Publikováno v:
AJR Am J Roentgenol
OBJECTIVE. The objective of this study was to assess to the role of contrast-enhanced digital mammography (CEDM) as a screening tool in women at intermediate risk for developing breast cancer due to a personal history of lobular neoplasia without add
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::295926917e870d0eeec261d6eb4ea7a4
https://doi.org/10.2214/ajr.20.23480
https://doi.org/10.2214/ajr.20.23480
Autor:
Jonathan M Olson, Molly T Hogan, Leonard M Pogach, Mangala Rajan, Gregory J Raugi, Gayle E Reiber
Publikováno v:
Patient Preference and Adherence, Vol 2009, Iss default, Pp 45-50 (2009)
Jonathan M Olson1, Molly T Hogan2, Leonard M Pogach3, Mangala Rajan3, Gregory J Raugi4, Gayle E Reiber51University of Washington School of Medicine, Seattle, WA, USA; 2Department of Internal Medicine, University of Washington School of Medicine, Seat
Externí odkaz:
https://doaj.org/article/2aabb4ed027b459c981ae11eca738c24
Autor:
Varadan Sevilimedu, Stefanie Jacobs, Janice S. Sung, Maxine S. Jochelson, Molly P Hogan, Tali Amir
Publikováno v:
AJR Am J Roentgenol
BACKGROUND. Contrast-enhanced digital mammography (CEDM) has been shown to outperform standard mammography while performing comparably to contrast-enhanced MRI. OBJECTIVE. The purpose of our study was to compare imaging characteristics of false-posit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22832dbc6e6d86ed32374fdb186047e4
https://europepmc.org/articles/PMC9110098/
https://europepmc.org/articles/PMC9110098/
Autor:
Molly P Hogan, Mithat Gonen, Monica Morrow, Clifford A. Hudis, Gary A. Ulaner, Debra A. Goldman, Maxine S. Jochelson, Joseph R. Osborne, Brittany Z. Dashevsky, Christopher C. Riedl
Publikováno v:
Journal of Nuclear Medicine. 56:1674-1680
Although guidelines such as those of the National Comprehensive Cancer Network consider 18F-FDG PET/CT for systemic staging of newly diagnosed stage III breast cancer patients, factors in addition to stage may influence the utility of PET/CT. Because
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88d058b0975467ab29f546f10c87c058
https://doi.org/10.2967/jnumed.115.161455
https://doi.org/10.2967/jnumed.115.161455
Intrathecal methotrexate is a standard option for central nervous system directed therapy in patients with stage III and IV diffuse large B-cell lymphoma. We present a case of a 50 year old man with stage IV diffuse large B-cell lymphoma with widespr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c17ac3c6e4f3707bfff8e52979549828
https://europepmc.org/articles/PMC5583704/
https://europepmc.org/articles/PMC5583704/